Showing 221-240 of 371 for: Cochrane Systematic Reviews > Oncology 
- Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
Cochrane Systematic Reviews, 3-Jun-2009
Hormone therapy for early prostate cancer has demonstrated an improvement in clinical and pathological variables, but not always an improvement in overall survival. We performed a systematic review of both adjuvant and neo-adjuvant hormone therapy combine
- Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
Cochrane Systematic Reviews, 21-Jan-2009
Hepatocellular carcinoma is a disease of great concern. Surgery is the treatment of choice, but there is still a high recurrence rate after resection.
- Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer
Cochrane Systematic Reviews, 30-Jul-2021
Epithelial ovarian cancer presents at an advanced stage in the majority of women. These women require a combination of surgery and chemotherapy for optimal treatment. Conventional treatment has been to perform surgery first and then give chemotherapy. How
- Neo-adjuvant chemotherapy for invasive bladder cancer
Cochrane Systematic Reviews, 17-Jan-2012
Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials (RCTs) involving over 3000 patients.
- Neoadjuvant chemotherapy for locally advanced cervix cancer
Cochrane Systematic Reviews, 19-Apr-2004
The impact of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer remains uncertain.
- Neoadjuvant chemotherapy versus none for resectable gastric cancer
Cochrane Systematic Reviews, 29-Oct-2008
Gastric cancer is a major cause of cancer death, and many patients are only diagnosed when the cancer has reached an advanced stage. Neoadjuvant chemotherapy (NAC), that is, chemotherapy administered shortly before surgical treatment, could provide a meth
- Non-invasive interventions for improving well-being and quality of life in patients with lung cancer
Cochrane Systematic Reviews, 7-Sep-2011
This is an updated version of the original review published in Issue 4, 2004 of The Cochrane Library. Lung cancer is one of the leading causes of death globally. Despite advances in treatment, the outlook for the majority of patients remains grim and most
- Non‐pharmacological interventions for breathlessness in advanced stages of malignant and non‐malignant diseases
Cochrane Systematic Reviews, 22-Nov-2013
- Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stage IV colorectal cancer
Cochrane Systematic Reviews, 22-Jun-2012
In a majority of patients with stage IV colorectal cancer, the metastatic disease is not resectable and the focus of management is on how best to palliate the patient. How to manage the primary tumour is an important part of palliation. A small proportion
- Nonsteroidal anti‐inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas
Cochrane Systematic Reviews, 19-Apr-2004
There is evidence from experimental animals studies, prospective and retrospective observational studies that nonsteroidal anti-inflammatory drugs (NSAIDS) may reduce the development of sporadic colorectal adenomas (CRAs) and cancer (CRC) and may induce t
- Non‐surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis
Cochrane Systematic Reviews, 22-Jul-2002
Chronic radiation cystitis occurs a minimum of three months after completion of pelvic radiotherapy and represents a range of clinical symptoms for which there is as yet no recommended standard management.
- Non‐surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis
Cochrane Systematic Reviews, 25-Apr-2016
This is an update of a Cochrane review first published in 2002, and previously updated in 2007. Late radiation rectal problems (proctopathy) include bleeding, pain, faecal urgency, and incontinence and may develop after pelvic radiotherapy treatment for c
- NSAIDS or paracetamol, alone or combined with opioids, for cancer pain
Cochrane Systematic Reviews, 10-May-2011
NSAIDs are widely applied to treat cancer pain and are frequently combined with opioids in combination preparations for this purpose. However, it is unclear which agent is most clinically efficacious for relieving cancer-related pain, or even what may be
- Nutrition support for bone marrow transplant patients
Cochrane Systematic Reviews, 23-Mar-2017
This is an update of the original Cochrane review published in Issue 2, 2002. Bone marrow transplantation involves administration of toxic chemotherapy and infusion of marrow cells. After treatment, patients can develop poor appetite, mucositis and gastro
- Nutritional support in children and young people with cancer undergoing chemotherapy
Cochrane Systematic Reviews, 24-Aug-2015
It is well documented that malnutrition is a common complication of paediatric malignancy and its treatment. Malnutrition can often be a consequence of cancer itself or a result of chemotherapy. Nutritional support aims to reverse malnutrition seen at dia
- Opioids for the management of breakthrough pain in cancer patients
Cochrane Systematic Reviews, 12-Oct-2015
This review is an update of a previously published review in the Cochrane Database of Systematic Reviews (Issue 1, 2006). Breakthrough pain is a transient exacerbation of pain that occurs either spontaneously or in relation to a specific predictable or un
- Optimal primary surgical treatment for advanced epithelial ovarian cancer
Cochrane Systematic Reviews, 21-Sep-2016
Ovarian cancer is the sixth most common cancer among women. In addition to diagnosis and staging, primary surgery is performed to achieve optimal cytoreduction (surgical efforts aimed at removing the bulk of the tumour) as the amount of residual tumour is
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Cochrane Systematic Reviews, 8-Oct-2021
Oral anticoagulants may improve the survival of people with cancer through an antithrombotic effect, yet increase the risk of bleeding.
- Oral morphine for cancer pain
Cochrane Systematic Reviews, 22-Apr-2016
This is the third updated version of a Cochrane review first published in Issue 4, 2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many years to relieve pain. Oral morphine in either immediate release or modified release
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
Cochrane Systematic Reviews, 21-Sep-2016
Fever occurring in a neutropenic patient remains a common life-threatening complication of cancer chemotherapy. The common practice is to admit the patient to hospital and treat him or her empirically with intravenous broad-spectrum antibiotics. Oral ther
